Novel action of apolipoprotein E (ApoE): ApoE isoform specifically inhibits lipid-particle-mediated cholesterol release from neurons by Gong, Jian-Sheng et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
Molecular Neurodegeneration
Open Access Research article
Novel action of apolipoprotein E (ApoE): ApoE isoform specifically 
inhibits lipid-particle-mediated cholesterol release from neurons
Jian-Sheng Gong1,2, Shin-ya Morita3, Mariko Kobayashi, Tetsurou Handa3, 
Shinobu C Fujita4, Katsuhiko Yanagisawa1 and Makoto Michikawa*1
Address: 1Department of Alzheimer's Disease Research, National Institute for Longevity Sciences, 36-3, Morioka, Obu, Aichi 474-8522, Japan, 
2Pharmaceuticals and Medical Devices Agency, Tokyo, Japan, 3Department of Biosurface Chemistry, Graduate School of Pharmaceutical Sciences, 
Kyoto University, Kyoto 606-8501, Japan and 4Mitsubishikagaku Institute of Life Sciences, 11 Minamiooya, Machida, Tokyo 194-8511, Japan
Email: Jian-Sheng Gong - jsgong@riken.jp; Shin-ya Morita - smorita@kobepharma-u.ac.jp; Mariko Kobayashi - michi@nils.go.jp; 
Tetsurou Handa - handatsr@pharm.kyoto-u.ac.jp; Shinobu C Fujita - fujita@libra.ls.m-kagaku.co.jp; 
Katsuhiko Yanagisawa - katuhiko@nils.go.jp; Makoto Michikawa* - michi@nils.go.jp
* Corresponding author    
Abstract
Background: Since the majority of apolipoprotein E (apoE) existing in the cerebrospinal fluid is
associated with high-density lipoprotein (HDL), one should focus on the role of the apoE-HDL
complex rather than on that of free apoE in cholesterol metabolism in the central nervous system.
However, the apoE-isoform-specific effect of apoE-HDL on cholesterol transport remains
unclarified.
Results: Here we show that apoE3-HDL induced a marked cholesterol release from neurons,
while apoE4-HDL induced little. To elucidate the mechanism underlying this phenomenon, we used
a complex of lipid emulsion (EM) with recombinant apoE3 or apoE4 (apoE-EM) at various apoE
concentrations. When a small number of apoE molecules were associated with EM, apoE3- and
apoE4-EM, induced a marked cholesterol release to a level similar to that induced by EM alone.
However, when apoE at given concentrations was incubated with EM, apoE3-EM induced a marked
cholesterol release, while apoE4-EM induced little. Under these conditions, a greater number of
apoE4 molecules were associated with EM than apoE3 molecules. When an increasing number of
apoE molecules were associated with EM, both apoE3-EM and apoE4-EM induced little cholesterol
release. Preincubation with β-mercaptoethanol increased the number of apoE3 molecules
associated with EM similar to that of apoE4 molecules, indicating that the presence (apoE3) or
absence (apoE4) of intermolecular disulfide bond formation is responsible for the association of a
greater number of apoE4 molecules to EM than apoE3 molecules.
Conclusion: These results suggest that although apoE and a lipid particle are lipid acceptors, when
apoE and a lipid particle form a complex, apoE on the particle surface inhibits the lipid particle-
mediated cholesterol release from cells in an apoE-concentration-dependent manner.
Published: 15 May 2007
Molecular Neurodegeneration 2007, 2:9 doi:10.1186/1750-1326-2-9
Received: 14 March 2007
Accepted: 15 May 2007
This article is available from: http://www.molecularneurodegeneration.com/content/2/1/9
© 2007 Gong et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Molecular Neurodegeneration 2007, 2:9 http://www.molecularneurodegeneration.com/content/2/1/9
Page 2 of 11
(page number not for citation purposes)
Background
It has been shown that the prevalence of Alzheimer's dis-
ease (AD) is associated with the polymorphisms of genes
related to cholesterol metabolism, including apolipoprotein
E (apoE)[1], ATP-binding cassette transporter A1 (ABCA1)
[2], and CYP46, the gene encoding cholesterol 24-hydrox-
ylase [3,4]. However, before discussing the association of
altered cholesterol metabolism with AD pathogenesis,
one should delineate mutual interaction between choles-
terol metabolism in the circulation and that in the central
nervous system across the blood-brain barrier, and also
determine how cholesterol is transported within the cen-
tral nervous system and how altered cholesterol metabo-
lism induces AD pathologies. In the central nervous
system, apoE is one of the major lipid acceptors [5,6] and
interacts with ABCA1 [7] to remove cholesterol from cells
and generate HDL particles [8] in an apoE-isoform-spe-
cific manner [9-11]. This isoform-specific action of free
apoE to remove cholesterol and to generate HDL would
be a possible cause for the altered cholesterol metabolism
in an AD brain. On the other hand, it was shown that the
majority of apoE existing in cerebrospinal fluid (CSF) and
culture media is associated with HDL and the free form of
apoE is at a very low level in the CSF [5,6] and culture
media [10,12]. Thus, to determine the apoE-isoform-spe-
cific cholesterol transport in the central nervous system,
one should focus on the role of the apoE-HDL complex
rather than on that of free apoE.
Many studies have shown that HDL stimulates cholesterol
release from cultured cells [13-15]. It is believed that this
removal of cellular cholesterol induced by HDL involves
at least two different mechanisms working cooperatively.
One involves the biochemical pathway mediated by apol-
ipoproteins [16,17]. The other involves the physicochem-
ical pathway for the bidirectional movement of
cholesterol mediated by aqueous diffusion mechanism
[18,19]. However, how these two acceptors contribute
and modulate the cholesterol release remains to be clari-
fied. Our recent finding that the apoE-isoform-specific
ability to generate HDL is associated with an apoE-iso-
form-specific ratio of apoE molecules per HDL particle
[10] led us to examine the effect of apoE3- and apoE4-
containing HDLs or lipid emulsions (EMs) at different
apoE ratios on cholesterol release from neurons. Here we
show that apoE3-HDL induces a strong cholesterol
release, while apoE4-HDL induces a very weak release,
and that this isoform-specific effect of apoE associated
with lipid particle (HDL or EM) is due to the finding that
(1) apoE4 has a higher affinity to lipid particles and thus
a greater number of apoE4 molecules bind to lipid parti-
cles than apoE3, and (2) with increasing number of apoE
molecules covering the surface of lipid particle, both
apoE3 and apoE4 inhibit the lipid-particle-mediated cho-
lesterol release. These results suggest that both apoE and a
lipid particle are strong lipid acceptors; however, when
apoE forms a complex with a lipid particle, apoE on the
particle surface inhibits the lipid-particle-mediated cho-
lesterol release by covering its surface.
Results
ApoE-isoform-specific lipid release mediated by apoE3- 
and apoE4-containing HDL
Human apoE3- and apoE4-containing HDL (apoE3-HDL
and apoE4-HDL, respectively) were obtained from the
conditioned media of each culture as described in the
"Experimental Procedures". As many previous studies
demonstrated, apoE3-HDL promoted cholesterol and
phosphatidylcholine (PC) release from neurons in an
HDL-dose-dependent manner (Fig. 1A). In contrast, sur-
prisingly, the amounts of cholesterol and PC released
from cultured neurons in the presence of apoE4-HDL
remained very low at any HDL-cholesterol concentrations
examined (Fig. 1A). Because our previous study demon-
strated that apoE4-HDL contains apoE molecules twofold
those in apoE3-HDL per particle [10], we determined the
amount of apoE molecules in each HDL fraction added
and plotted against the amount of cholesterol and PC
released at various apoE concentrations. As shown in Fig.
1B, even when a comparable or a greater amount of apoE
molecules was included in the apoE4-HDL than that in
the apoE3-HDL, it did not promote lipid release, either
(Fig. 1B). Analysis of the time dependence of lipid release
mediated by apoE-HDL showed that lipid release medi-
ated by apoE-HDL reached the peak 60 min following the
addition of apoE3-HDL and apoE4-HDL (Fig. 2).
Effect of apoE-emulsion complex on cholesterol release 
from cultured neurons
To elucidate the mechanism underlying the apoE-iso-
form-specific effect on cholesterol release mediated by
apoE-HDL, we used a complex consisting of lipid emul-
sion (EM) and recombinant human apoE3 or apoE4,
because one cannot modulate the number of apoE mole-
cules associated with HDL, but one can modulate apoE
number associated with EM. Using this system, we can
investigate the effect of apoE on EM-mediated lipid efflux.
EM is generated using phosphatidylcholine and triolein
and its diameter was determined as described in the
Experimental Procedures, and the apoE-EM complexes
were then re-isolated before use for the various assays per-
formed. When EM was added to the neuronal cultures in
which cholesterol was labeled with 14C-acetate, choles-
terol and PC were released in a time- and an EM-dose-
dependent manner (Fig. 3), showing that EM serves as a
lipid acceptor to release cholesterol. Time-dependent
kinetics in terms of lipid release showed that the level of
lipids released into the conditioned media saturated 30
min following the commencement of treatment. We
determined the amounts of cholesterol and PC releasedMolecular Neurodegeneration 2007, 2:9 http://www.molecularneurodegeneration.com/content/2/1/9
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using EM particles at a PC concentration of 5 µg/ml 60
min following the commencement of treatment in the fol-
lowing experiments performed.
ApoE-dose-dependent inhibition of EM-mediated lipid 
release
We examined the dose-dependent effect of apoE associ-
ated with EM on apoE-EM-mediated lipid release. EM
alone and the apoE3- and apoE4-EM complexes induced
lipid release from neurons; however, with increasing con-
centration of apoE incubated with EM, the levels of lipid
released induced by both apoE3- and apoE4-EM com-
plexes decreased (Fig. 4). However, when the apoE-EM
complexes were generated by the incubation of apoE at
concentrations of 0.1 and 1 µg/ml with EM (at a PC con-
centration of 50 µg/ml) and were applied at a PC concen-
tration of 5 µg/ml, apoE3-EM strongly induced
cholesterol release, whereas apoE4-EM induced little. The
weight ratio of PC per apoE calculated in each treatment
is shown in Table 1. The ratio of ratio of PC per apoE at
apoE concentrations of 0.1,1,10, and 30 µg/ml was greater
in the apoE3-EM complex than in the apoE4-EM complex,
Characterization of cholesterol and PC release from cultured neurons in the presence of apoE3-HDL or apoE4-HDL Figure 1
Characterization of cholesterol and PC release from cultured neurons in the presence of apoE3-HDL or 
apoE4-HDL. Neurons labeled with 37 Bq/ml [14C] acetate were cultured for 3 days at 37°C. These neurons were washed in 
DMEM three times and incubated in DMEM for 1 h in the presence of apoE3-HDL or apoE4-HDL at various ApoE or HDL 
cholesterol concentrations, and the amounts of released [14C]-labeled cholesterol and PC were determined. A) The amounts 
of cholesterol and PC released, as induced by apoE3-HDL (❍ ), were significantly greater than those of cholesterol and PC 
released, as induced by apoE4-HDL (● ). B) The amounts of cholesterol and PC are plotted against the concentrations of apoE 
associated with HDL. Data are means ± S.E. of four samples. *p < 0.05 and **p < 0.001 vs apoE4-HDL at various cholesterol 
concentrations. Six independent experiments show similar results.
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indicating that apoE4 has higher binding affinity to EM
than apoE3. Interestingly, when the ratios (PC/apoE)
were (a) 496 ± 97 (for apoE3) and 269 ± 85 (for apoE4),
and (b) 23 ± 6 (for apoE3) and 16 ± 6 (for apoE4), which
were obtained by incubating EM with apoE at concentra-
tions of (a) 0.1 and (b) 1.0 µg/ml, respectively (Table 1),
the apoE-isoform-specific cholesterol release was
observed (Fig. 4) as was the case for apoE-HDL (Fig. 1),
that is, apoE3-EM and apoE3-HDL induced cholesterol
release from neurons, whereas apoE4-EM and apoE4-
HDL induced little release.
We next examined whether the formation of the apoE-EM
complex is required for apoE to attenuate the EM-medi-
ated lipid release. When apoE3 and apoE4 at 10 µg/ml
were preincubated with 5 µg/ml EM, lipid release in the
presence of apoE3-EM or apoE4-EM was significantly
reduced compared with that in the presence of EM. On the
other hand when they were added into the culture
medium without preincubation, they did not inhibit lipid
release mediated by EM (Fig. 5).
Dimerization of apoE3 via disulfide bonds alters binding 
affinity of apoE3 to be similar to that of apoE4
Because apoE3 differs from apoE4 by one amino acid at
residue 152 having cysteine instead of arginine, we exam-
EM mediated cholesterol and PC release from cultured neu- rons Figure 3
EM mediated cholesterol and PC release from cul-
tured neurons. Neurons labeled with 37 Bq/ml [14C]ace-
tate were cultured for 3 days at 37°C. These neurons were 
washed in DMEM three times and further incubated in 
DMEM for 1 h (a) or various times (b) in the presence of EM 
at various PC concentrations. The conditioned media were 
then collected and the amounts of [14C]-labeled cholesterol 
and PC were determined. (a) EM-induced cholesterol (❍ ) 
and PC (● ) release from cultured neurons occurs in an EM-
PC-dose-dependent manner. (b) The time-dependent 
release of cholesterol (❍ ) and PC (● ) from cultured neurons 
in the presence of EM at PC concentration of 5 µg/ml is 
shown. Data are means ± S.E. of four samples. *p < 0.0001 
and **p < 0.001 vs PC at 0 ng/ml and time at 0 h. Four inde-
pendent experiments showed similar results.
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Time-dependent release of cholesterol and PC from 
cultured neurons in the presence of apoE3-HDL or 
apoE4-HDL. The kinetics of cholesterol and PC release in 
the presence of apoE3- or apoE4-HDL at a cholesterol con-
centration of 500 ng/ml were determined. Both apoE3- (❍ ) 
and apoE4-HDL (● ) induced cholesterol and PC release in a 
time-dependent manner. Data are means ± S.E. of four sam-
ples. *p < 0.001 and **p < 0.0001 vs apoE4-HDL. Six inde-
pendent experiments showed similar results.
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ined whether the dimerization of apoE3 molecules via
disulfide bonds is responsible for the apoE-isoform-spe-
cific binding affinity to lipids. In the presence of 5% β-
mercaptoethanol, the binding affinity of apoE3 increased
to a level similar to that of apoE4 (Fig. 6). The next ques-
tion is whether EM associated with apoE3 preincubated
with β-mercaptoethanol, loses its ability to release choles-
terol. However, this experiment was difficult to perform
due to the toxic effect of β-mercaptoethanol on neurons.
Discussion
Previous studies showed that HDL induces cholesterol
release from various cell types [15,18,20]. The present
study also showed that apoE3-HDL induced a strong cho-
lesterol release, whereas apoE4-HDL induced a weak cho-
lesterol release from neurons. As a mechanism underlying
this apoE-isoform specificity, we showed a novel action of
apoE, that is, although apoE is a lipid acceptor, when
apoE is associated with lipid particles such as HDL and
EM, apoE inhibits lipid-particle-mediated cholesterol
release in an apoE-dose-dependent manner. We also
found that more apoE4 molecules are associated with
HDL or EM than apoE3. This may explain why apoE4
associated with HDL or EM inhibits HDL- or EM-medi-
ated cholesterol release, whereas apoE3 does not. We also
found that the dimerization of apoE3 by disulfide bonds
causes the apoE-isoform dependence of the apoE binding
affinity to lipids.
Cellular cholesterol release is mediated by two distinct
mechanisms. One is the reaction of lipid-free apolipopro-
teins, such as apoE or apoAI, and any other molecules
containing a certain amount of amphipathic α-helix with
a cellular surface protein, ABCA1, resulting in the removal
of cellular lipids and the subsequent generation of HDL-
like particles [16,21]. The other one is a nonspecific phys-
icochemical interaction causing cholesterol diffusion and
its exchange between plasma membrane and lipid parti-
cles mediated by EM and liposomes. The cellular choles-
terol release mediated by HDL likely involves both
mechanisms, because HDL in the central nervous system
contains at least two potential acceptors, apoE and lipids.
One may reasonably raise questions as to which apoE iso-
form and to what extent lipids contribute to the HDL-
mediated cholesterol release. Previous studies showed
that apolipoprotein AI (apoAI) dissociated from HDL
cooperatively induces cholesterol release [21,22] and that
cholesterol release mediated by HDL is, in part, mediated
by apoAI dissociated from HDL in an ABCA1-dependent
manner [23]. However, our previous study showed that
the level of free apoE in conditioned media and physio-
logical fluid is underdetectable and almost all of the apoE
is recovered from the HDL fraction [10].
Table 1: Binding of apoE3 and apoE4 molecules to emulsion 
particles
apoE concentration (µg/ml) 0.1 1 10 30
Weight ratio of PC per apoE apoE3 496 ± 97 23 ± 6 7 ± 2 8 ± 3
apoE4 269 ± 85 16 ± 6 6 ± 1 7 ± 1
Lipid emulsions were prepared by the method described previously 
[36] using a high-pressure emulsifier. The emulsion used had a particle 
size of 34.7 ± 5.2 nm and a weight ratio of TO/PC was 1.63 ± 0.07. 
For the generation of apoE-EM complex, apoE at various 
concentrations, from 0.1 to 30 µg/ml, was incubated with EM at PC 
concentration of 5.0 µg/ml in a 5-ml solution for 1 hr at room 
temperature. The apoE-EM complex was isolated and assayed by the 
untracentrifugation method as previously reported [24, 37]. The 
weight ratio of apoE and PC were determined as described in the 
Experimental Procedures. Data are means ± S.E. of four samples.
Effect of apoE associated with EM on EM-mediated choles- terol and PC release Figure 4
Effect of apoE associated with EM on EM-mediated 
cholesterol and PC release. Cultured neurons were incu-
bated with serum-free N2 medium containing 37 Bq/ml 
[14C]acetate for 3 days at 37°C. These neurons were washed 
in DMEM three times and further incubated in DMEM for 1 h 
in the presence of the apoE-EM complex at various apoE 
concentrations. The conditioned media were then collected 
and the amounts of [14C]-labeled cholesterol and PC 
released were determined. The amounts of cholesterol and 
PC released into the conditioned media in the presence of 
apoE3-EM (❍ ) or apoE4-EM (● ) are shown. Data are means 
± S.E. of four samples. *p < 0.01 and **p < 0.005 vs apoE4-
EM. Six independent experiments showed similar results.
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Dimerization of apoE3 by disulfide bonds causes the differ- ence in apoE isoform-specific binding affinity Figure 6
Dimerization of apoE3 by disulfide bonds causes the 
difference in apoE isoform-specific binding affinity. 
EM and apoE3 (or apoE4) were incubated in the presence or 
absence of 5% β-mercaptoethanol for 1 h and EM-PC con-
centrations and the number of apoE molecules in the apoE-
EM complex was determined as described in the Experimen-
tal Procedures. Data are means ± S.E. of three samples. *p < 
0.001. Three independent experiments showed similar 
results.
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Moreover, as we previously reported [10], apoE4-HDL
contains number of apoE molecules per particle twofold
that of apoE3; however, apoE4-HDL induced a very-weak
cholesterol release, whereas apoE3-HDL induced a strong
cholesterol release (Figs. 1A and 1B). These results suggest
that HDL harboring apoE4 on its surface does not induce
cholesterol release. That is, apoE4 on the HDL surface
inhibits cholesterol release mediated by HDL. This notion
is confirmed by our experiments performed to determine
the effect of apoE on EM-induced cholesterol release using
the apoE-EM complex at various apoE concentrations on
the EM surface, that is, with increasing number of apoE
molecules associated with EM, not only apoE4-EM, but
also apoE3-EM lose their ability to induce cholesterol
release, suggesting that apoE associated with EM strongly
inhibits EM-mediated cholesterol release. Interestingly,
the apoE-EM complex at certain apoE concentrations and
apoE/EM particle ratios induces cholesterol release in an
apoE-isoform-specific manner; apoE-EM3 induces choles-
terol release, but apoE4-EM does not (Fig. 4), as observed
in the cases of apoE3-HDL and apoE4-HDL (Fig. 1). As
shown previously [24], our data confirm that more apoE4
molecules are associated with HDL or EM than apoE3
(Table 1). These results lead us to propose a novel hypoth-
esis that apoE molecules covering the surface of lipid par-
ticles inhibit the physicochemical interaction occurring
between lipids and cell membrane. There are greater num-
bers of apoE4 molecules associated with EM and HDL,
which in turn inhibit the EM- and HDL-mediated physic-
ochemical exchange of cholesterol, whereas in the case of
apoE3, the smaller number of apoE3 molecules on the EM
or HDL surface allows cholesterol influx to EM or HDL
surface from the cell membrane (Fig. 7b).
One may raise the issue that apoE-HDL/EM internaliza-
tion via several apoE receptors expressed on neurons and
recycled-apoE-mediated cholesterol efflux may explain
apoE-isoform-dependent cholesterol efflux induced by
apoE-HDL/EM. The recycle of apoE4 has been shown to
be significantly decreased, resulting in a decreased level of
cholesterol efflux [25]. Thus, it is possible that the poor
recycling of internalized apoE4 is responsible for the
reduced ability of apoE4-containing particles to release
cholesterol from neurons. However, the observation that
a greater amount of apoE3 associated with EM induces a
smaller amount of cholesterol efflux compared with EM
without apoE3 (Fig. 4) indicates that this is not the case.
It has been shown that HDL in the central nervous system
contains apoE and that neurons express apoE receptors
[26]. Thus, different from HDL in systemic circulation,
HDL in the central nervous system is internalized into
cells via apoE receptors to supply cholesterol to neurons
(Fig. 7a). One may question, which is the net cholesterol
transport, release from or supply to cells, in the presence
of apoE-HDL and apoE-EM? It has been shown that HDL
serves as the net cholesterol supplier to neurons. Previous
studies showed that HDL promotes synaptogenesis [27],
synaptic plasticity [28], and elongation of axons [29], and
strongly suppresses cholesterol synthesis (unpublished
data), indicating that HDL-cholesterol is taken up by neu-
rons and used for axonal elongation and synaptogenesis.
If HDL, as a whole, functions as a net cholesterol supplier
to neurons, what is the biological significance of apoE-
HDL-mediated cholesterol release from neurons? Because
physicochemical interaction causes a bidirectional choles-
terol exchange (nonspecific cholesterol diffusion)
between HDL cholesterol and cholesterol in the plasma
membrane, it is reasonable to assume that cholesterol
exchange may contribute to the maintenance of a fresh
supply of cholesterol in the plasma membrane by replac-
ing accumulated oxidized cholesterol in the membrane.
Thus, the isoform-specific apoE-HDL action on choles-
terol exchange suggests that the apoE3-HDL complex has
a greater ability to maintain a fresh supply of cholesterol
in the plasma membrane (Fig. 7b). The lower ability of
apoE4-HDL may result in the accumulation of oxysterols
in the plasma membrane, leading to altered membrane
functions e.g., signal transduction, enzyme activities, and
ion channel properties.
The last issue to be addressed is the cause of the apoE-iso-
form dependence of the preferential association of apoE
with HDL and EM particles. Previous studies showed that
apoE3 forms a disulfide-linked homodimer in plasma
[30] and in culture media [10]. Thus, we determined
whether this dimerization of apoE3 is responsible for the
lesser number of apoE3 molecules associated with EM.
The treatment of apoE3 with β-mercaptoethanol signifi-
cantly increased the number of apoE3 molecules associ-
ated with EM (Fig. 6), indicating that when apoE3
remains as a monomer, more apoE3 monomers can asso-
ciate with EM than apoE3 dimers. The next question is
whether EM associated with apoE3, which is treated with
β-mercaptoethanol, loses its ability to induce strong cho-
lesterol release. However, this experiment is difficult to
perform due to toxic effect of β-mercaptoethanol on neu-
rons. Regarding the effect of apoE polymorphism on lipid
interaction, it has been suggested that domain interaction
mediated by a salt bridge between Arg-61 in the N-termi-
nus and Glu-255 in the C-terminus, leading to a compact
structure, results in the preferential binding of apoE4 to
very low density lipoproteins [11,31,32]. The apoE4
domain interaction has been observed in vivo in Arg-61
knock-in mice [33]. Taken all together, it is possible that
in addition to structural differences within an apoE mole-
cule such as domain interaction, dimerization also has an
effect on the apoE structure (which may also affect
domain interaction), leading to the enhancement of theMolecular Neurodegeneration 2007, 2:9 http://www.molecularneurodegeneration.com/content/2/1/9
Page 8 of 11
(page number not for citation purposes)
Schema showing the apoE-isoform-specific effect of apoE-HDL and apoE-EM complex on HDL- and EM-mediated cholesterol  release Figure 7
Schema showing the apoE-isoform-specific effect of apoE-HDL and apoE-EM complex on HDL- and EM-medi-
ated cholesterol release. Lipid-free apoE3 released from astrocytes generates a greater number of HDL particles than 
apoE4 with a similar number of apoE molecules [10], indicating that apoE3-expressing astrocytes can supply more cholesterol 
as HDL to neurons via apoE receptors (a). Lipid particles such HDL and EM have another role in cholesterol metabolism, that 
is, physicochemical and nonspecific cholesterol exchange between lipid particles and the cell membrane. Our present results 
show that with increasing number of apoE molecules on the particle surface, apoE inhibits the particle-mediated cholesterol 
exchange (b). Because a greater number of apoE4 molecules bind to lipid particles (HDL and EM) than apoE3 molecules, apoE4 
inhibits cholesterol exchange (release) by covering the lipid surface, whereas a smaller number of apoE3 molecules on lipid par-
ticle surface allows apoE3-HDL- or apoE3-EM-mediated cholesterol release (b).
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apoE-isoform-specific effect on the interaction between
apoE and lipids.
Conclusion
Here we have shown that although apoE and a lipid par-
ticle such as EM are lipid acceptors, when apoE and a lipid
particle form a complex, apoE inhibits the lipid particle-
mediated cholesterol release from cells in an apoE-dose-
dependent manner, probably owing to the occupation of
the surface of the lipid particle, thereby inhibiting lipid
diffusion and exchange. The observation that a greater
number of apoE4 molecules are associated with EM than
apoE3 may explain the apoE-isoform-dependent lipid
release induced by the apoE-lipid complex. Because lipid
particles such HDL and EM induce physicochemical and
nonspecific cholesterol exchange between lipid particles
and the cell membrane, the lower ability of the apoE4-
lipid complex to release lipids may result in the lower
lipid replacement and accumulation of oxysterols in the
plasma membrane, leading to altered membrane func-
tions, e.g., signal transduction, enzyme activities, and ion
channel properties.
Methods
Animals
The animal care and the experiments using animals were
carried out in accordance with institutional guidelines.
Mice expressing human apoE4 in place of mouse apoE
were generated by the gene-targeting technique taking
advantage of homologous recombination in embryonic
stem cells (knock-in) as previously described [34]. ApoE3
knock-in mice were generated in the same manner except
that the transgene carried apoE3 cDNA in place of apoE4
cDNA. Postnatal day 2 mice that possess the homozygous
epsilon 3 (3/3) or epsilon 4 (4/4) allele, and correctly
expressing human apoE3 or apoE4 proteins, respectively,
were used in this study.
Cell culture
Highly astrocyte-rich cultures were prepared according to
a previously described method [10]. In brief, the brains of
postnatal day 2 mice were removed under anesthesia. The
cerebral cortical fragments were incubated in 0.25%
trypsin and 20 mg/ml DNase I in phosphate-buffered
saline (PBS) (8.1 mM Na2HPO4,1.5 mM KH2PO4O, 137
mM NaCl and 2.7 mM KC1, pH 7.4) at 37°C for 20 min.
The fragments were then dissociated into single cells by
pipetting. The dissociated cells were seeded in 75-cm2
dishes at a cell density of 1 × 107 in Dalbecco's modified
essential medium (DMEM) containing 10% FBS. After 10
days of incubation in vitro, astrocytes in the monolayer
were trypsinized (0.1%) and reseeded onto six-well dishes
and maintained in DMEM containing 10% FBS until use.
Neuron-rich cultures were prepared from rat cerebral cor-
tices as previously described [35]. Dissociated cells were
suspended in the feeding medium and plated onto poly-
D-lysine-coated twelve-well plates at a cell density of 2 ×
105/cm2. The feeding medium consisted of DMEM nutri-
ent mixture (DMEM/F12; 50%: 50%) and N2 supple-
ments. More than 99% of the cultured cells were
identified as neurons by immunocytochemical analysis
using a monoclonal antibody against microtubule-associ-
ated protein 2, a neuron-specific marker, on day 3 of cul-
ture.
Preparation of HDL released into conditioned media of 
astrocytes expressing apoE3 or apoE4
Astrocytes in 75-cm2 dishes were washed in DMEM three
times and incubated in 12 ml of DMEM for 5 days at
37°C. After incubation, the astrocyte culture medium was
collected, centrifuged at 1, 600 × g for 15 min in a 50-ml
plastic tube to exclude cell debris, and adjusted to a dis-
continuous sucrose gradient, which was prepared in a 14
× 89 mm ultracentrifuge tube (Ultraclear, Beckman, Palo
Alto, CA) from the bottom to the top, with 1.5 ml of
sucrose at a density of 1.30 g/ml, 3 ml at 1.20 g/ml, 4.5 ml
at 1.10 g/ml, and 3 ml at 1.006 g/ml medium. The sample
in the sucrose gradient was then centrifuged in an SW41-
Ti swing rotor (Beckman, Palo Alto, CA) at 16°C for 48 h
at 160,000 × gav. Following density gradient centrifuga-
tion, twelve 1.0-ml fractions were collected with a mirco-
pipette from the top gradient. The final fraction was
stirred to resuspend the pellet. The density of each fraction
was determined using a density meter, DMA35N (Anton
Paar, Graz, Austria).
Preparation of lipid emulsions (EM) and apoE-EM 
complex
Egg yolk phosphatidylcholine (PC) was kindly provided
by Asahi Kasei (Tokyo, Japan). Triolein (TO) was pur-
chased from Sigma (St. Louis, MO). Lipid emulsions were
prepared by the method described previously [36] using a
high-pressure emulsifier (Nanomizer System YSNM-
2000AR; Yoshida Kikai Co., Nagoya, Japan). The mixture
of TO and PC at a weight ratio of 1:1 was suspended in
50% glycerol in 10 mM Tris-HCl buffer (pH 7.4) contain-
ing 150 mM NaCl, 1 mM EDTA and 0.01% NaN3, and
subsequently emulsified under 140 MPa of pressure at
60°C. Glycerol was exhaustively removed by dialysis
against PBS overnight. The contaminating vesicles and
larger particles were removed by ultracentrifugation. The
weight-averaged particle size of emulsions was 34.7 ± 5.2
nm determined from dynamic light scattering measure-
ments (Photal LPA-3000/3100; Otsuka Electronic Co.,
Osaka, Japan). The concentrations of TO and PC were
determined using enzymatic assay kits purchased from
Wako Pure Chemicals (Osaka, Japan). After ultracentrifu-
gation, the weight ratio of TO/PC was 1.63 ± 0.07 (meanMolecular Neurodegeneration 2007, 2:9 http://www.molecularneurodegeneration.com/content/2/1/9
Page 10 of 11
(page number not for citation purposes)
± S.D., n = 5). For the generation of the apoE-EM complex,
apoE at various concentrations, from 0.001 to 30 µg/ml,
was incubated with EM at a PC concentration of 50 µg/ml
in a 5 ml solution for 1 h at room temperature. The apoE-
EM complex was isolated and assayed by the ultracentrif-
ugation method as previously reported [24,37].
Lipid analysis
The extraction of lipids and the subsequent determination
of the amounts of cholesterol and phospholipids in the
HDL fraction were carried out according to previously
described methods [9]. Aliquots (1.0 ml) of conditioned
culture media were transferred to clean glass tubes con-
taining 5.0 ml of chloroform: methanol (2:1 v/v). The
organic phases were removed, evaporated under N2 gas,
followed by redissolution in 50 µl of isoprapanol for lipid
assay. The amount of total cholesterol was determined
using a cholesterol determination kit, LTCII (Kyowa
Medex, Tokyo, Japan). The amount of phospholipids was
determined using a phospholipid determination kit, PLB
(Wako, Osaka, Japan). For the determination of PC level
in the apoE+EM complex in the presence of 5% β-mercap-
toethanol, PC was extracted with chloroform: methanol
(2:1 v/v) as described above. The organic phases were
removed, evaporated under N2 gas. The samples were
redissolution in 20 µl of chloroform: methanol (2:1 v/v)
and 5 µl of each solution was spotted on a chromarod-SIII
quartz rod and analyzed by thin-layer chromatography/
flameionization detector (Iatroscan MK-5 ; Iatron Lab.,
Inc., Tokyo, Japan).
Determination of amount of cholesterol and 
phosphatidylcholine released from neurons labeled with 
[14C]acetate
Neurons cultured for 2 days were labeled with 37 Bq/ml
[14C] acetate (DuPont NEN) for another 2 days. Two days
later, these neurons were washed three times with 1.5 ml
of DMEM and incubated in DMEM containing reagents
such as apoE3-HDL, apoE4-HDL, apoE3-EM, or apoE4-
EM at various concentrations. Aliquots of 1.0 ml each of
the conditioned culture media were transferred to clean
glass tubes containing 5.0 ml of hexane:isopropanol (3:2
v/v). For the extraction of intracellular lipids, dried cells
were incubated in hexane:isopropanol (3:2 v/v) for 1 h at
room temperature. The solvent from each sample was
evaporated and the organic phases were redissolved in 20
µl (for the condition medium) and 200 µl (for the cells)
of chloroform, and 10 µl of each sample was spotted on
activated silica gel high-performance thin-layer chroma-
tography (HPTLC) plates (Merck, Darmstadt, Germany);
the lipids were separated by sequential one-dimensional
chromatography using chloroform: methanol: acetic acid:
water (25:15: 4: 2, v/v/v/v), followed by another run in
hexane: diethylether: acetic acid (80: 30: 1). [14C]-Choles-
terol and [14C]-phosphatidylcholine were used as stand-
ards. The chromatography plates were exposed to
radiosensitive films and each lipid was visualized and
quantified with BAS2500 (Fuji Film, Tokyo, Japan).
Immunoblot analysis
Samples of each fraction were dissolved in the sample
buffer consisting of 100 mM Tris-HCl (pH 7.4), 10% glyc-
erol, 4% SDS, 10% mercaptoethanol and 0.01%
bromophenol blue, and analyzed by 4–20% gradient
Trids/tricine SDS-PAGE as previously reported [38]. The
separated proteins were transferred onto Immobilon
membranes with a semidry electrophoretic transfer appa-
ratus (Nihon Eido, Tokyo, Japan) using a transfer buffer
(0.1 M Tris, 0.192 M glycine and 20% methanol). Blots
were probed for overnight at 4°C with a goat anti-apoE
polyclonal antibody, AB947 (1: 2,000; Chemicon, Temec-
ula, CA). Bands were detected using an ECL kit (Amer-
sham Pharmacia Biotech, UK). For the determination of
the concentration of apoE released into the culture
medium, signals corresponding to apoE of each sample in
the immunoblot membrane were quantified by densit-
ometry using NIH image software, at varying concentra-
tions of synthetic apoE protein (Wako, Tokyo, Japan) as
standards. Standard signals were demonstrated to be lin-
ear in the range of apoE protein amounts from 0 to 2 µg
per lane. ApoE concentrations in the HDL fraction and
apoE-EM complex fraction within this range were used for
analysis. For immunoblot analysis using anti-ABCAl anti-
body, the cultured neurons in a 6-well plate were washed
in cold PBS and harvested in 500 µl of 50 mM Tric-HCl
(Ph 7.4) solution containing 2 mM EGTA. The cell lysates
were sonicated and centrifuged at 700 rpm for 10 min at
4°C. The supernatant of each sample was centrifuged at
14,000 rpm for 20 min at 4°C, and the pellet fractions
were resuspended in DW containing 0.45 M Urea, 0.1%
TritonX-100, and 0.05% Dithiothretol and used for
immunoblot analysis as described above.
Statistical analysis
StatView computer software (Windows) was used for sta-
tistical analysis. Statistical significance of differences
between samples was evaluated by multiple pairwise com-
parison among the sets of data using ANOVA and the
Bonferoni t-test.
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